Epiphora after radioactive iodine ablation for thyroid cancer

Thyroid

Volumn 23, Issue 2, 2013, Pages 243-245

  Sun, Grace E Ching ^a   Hatipoglu, Betul ^b  

^a Louisiana State University Health Sciences Center   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ABLATION THERAPY; ADULT; ARTICLE; CASE REPORT; DACRYOCYSTORHINOSTOMY; DIFFERENTIATED THYROID CANCER; EPIPHORA; FEMALE; FOLLOW UP; HUMAN; NASOLACRIMAL DUCT STENOSIS; OCCLUSION; PRIORITY JOURNAL;

ADULT; CARCINOMA; DACRYOCYSTORHINOSTOMY; FEMALE; HUMANS; IODINE RADIOISOTOPES; LACRIMAL APPARATUS DISEASES; LACRIMAL DUCT OBSTRUCTION; THYROID NEOPLASMS;

EID: 84873674551     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0186     Document Type: Article

References (18)

1. Seidlin SM, Marinelli LD, Oshray E 1946 Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid. J Am Med Assoc 132:838-847
2. Burns JA, Morgenstern KE, Cahill KV, Foster JA, Jhiang SM, Kloos RT 2004 Nasolacrimal obstruction secondary to I(131) therapy. Ophthal Plast Reconstr Surg 20:126-129
3. Kloos RT, Duvuuri V, Jhiang SM, Cahill KV, Foster JA, Burns JA 2002 Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab 87:5817-5820
4. Morgenstern KE, Vadysirisack DD, Zhang Z, Cahill KV, Foster JA, Burns JA, Kloos RT, Jhiang SM 2005 Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients. Ophthal Plast Reconstr Surg 21:337-344
5. Spitzweg C, Joba W, Schriever K, Goellner JR, Morris JC, Heufelder AE 1999 Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab 84:4178-4184
6. Solans R, Bosch JA, Galofre P, Porta F, Rosello J, Selva-O'Callagan A, Vilardell M 2001 Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med 42:738-743
7. Zettinig G, Hanselmayer G, Fueger BJ, Hofmann A, Pirich C, Nepp J, Dudczak R 2002 Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study. Eur J Nucl Med Mol Imaging 29:1428-1432
8. Fard-Esfahani A, Mirshekarpour H, Fallahi B, Eftekhari M, Saghari M, Beiki D, Ansari-Gilani K, Takavar A 2007 The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma. Clin Nucl Med 32:696-699
9. Shepler TR, Sherman SI, Faustina MM, Busaidy NL, Ahmadi MA, Esmaeli B 2003 Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma. Ophthal Plast Reconstr Surg 19:479-481
10. Brockmann H, Wilhelm K, Joe A, Palmedo H, Biersack HJ 2005 Nasolacrimal drainage obstruction after radioiodine therapy: case report and a review of the literature. Clin Nucl Med 30:543-545
11. Bakheet SM, Hammami MM, Hemidan A, Powe JE, Bajaafar F 1998 Radioiodine secretion in tears. J Nucl Med 39:1452-1454
12. Groessl SA, Sires BS, Lemke BN 1997 An anatomical basis for primary acquired nasolacrimal duct obstruction. Arch Ophthalmol 115:71-74
13. McCormick A, Sloan B 2009 The diameter of the nasolacrimal canal measured by computed tomography: gender and racial differences. Clin Experiment Ophthalmol 37:357-361
14. Seider N, Miller B, Beiran I 2008 Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction. Am J Ophthalmol 145:120-123
15. Kintzel PE, Michaud LB, LangeMK 2006 Docetaxel-associated epiphora. Pharmacotherapy 26:853-867
16. McCartney E, Valluri S, Rushing D, Burgett R 2007 Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel. Ophthal Plast Reconstr Surg 23:170-171
17. Brink HM, Beex LV 1995 Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature. Doc Ophthalmol 90:1-6
18. Lee SL 2010 Complications of radioactive iodine treatment of thyroid carcinoma. J Natl Compr Canc Netw 8: 1277-87